Skip to content

Rectus Sheath Block in Cardiac Surgery

Rectus Sheath Block in Cardiac Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05833048
Enrollment
75
Registered
2023-04-27
Start date
2024-07-29
Completion date
2026-12-31
Last updated
2026-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease, Postoperative Pain

Keywords

cardiac surgery, regional anesthesia

Brief summary

This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block. 1. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery? 2. Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.

Interventions

PROCEDURERectus sheath block

Participants will receive an ultrasound guided rectus sheath block with local anesthetic

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* In order to be eligible to participate in this study, an individual must meet all of the following criteria: 1. Adults 18-85 years old 2. Scheduled to undergo cardiac procedures involving chest tubes 3. Male or female

Exclusion criteria

* An individual who meets any of the following criteria will be excluded from participation in this study: 1. ASA class V 2. Urgent or emergent surgery 3. Contraindications to administration of local anesthesia (e.g. local anesthetic allergy) 4. History of substance abuse or chronic opioid use 5. Patient refusal or inability to consent

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumption72 hours postoperativelyAmount of opioid consumption required postoperatively
VAS pain scores72 hours postoperativelyVAS pain scores (1-10, 1 being no pain and 10 being worst pain) recorded postoperatively

Secondary

MeasureTime frameDescription
Length of stay in ICU72 hoursAmount of time spent in ICU postoperatively
Length of hospital stay72 hoursLength of time spent in hospital postoperatively
Time to extubation72 hoursLength of time requiring postoperative mechanical ventilation

Countries

United States

Contacts

CONTACTAli Shariat, MD
AliNima.Shariat@mountsinai.org212-523-2500
CONTACTHimani Bhatt, DO
himani.bhatt@mountsinai.org212-523-2500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 1, 2026